Skip to Main Content

Advertisement

Skip Nav Destination

Editor's Corner


Remembering Kristin Hubing

August 2022

Mikkael Sekeres, MD, David Steensma, MD, and Aaron Gerds, MD

On July 8, 2022, our managing editor for ASH Clinical News, Kristin Hubing, left this earth at a devastatingly young age for what we hope is a more joyous place. She left behind her husband Kyle and her infant son Theo, along with scores of family, friends, and her work family at ASH. Her death leaves a huge hole in all our hearts.

From the Desk Of...

August 2022

Dr. Gerds shares his thoughts on the August issue including the relevance of the feature story on marijuana, the link between lenalidomide and the risk of therapy-related myeloid neoplasms, and more.

Immune Response Muted in Patients With NHL/CLL Who Are Vaccinated Against COVID-19

August 2022

A study published in Journal of Clinical Oncology found that such patients’ antibody binding and neutralization against the original SARS-CoV-2 virus and variants such as Delta and Omicron were substantially lower compared to healthy vaccinees.

Lenalidomide Linked to Risk of Therapy-Related Myeloid Neoplasms

August 2022

“Our result might offer a personalized approach to reducing the risk of t-MNs,” said study researcher Koichi Takahashi, MD, PhD, of the University of Texas MD Anderson Cancer Center.

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement